Comparison of Kaplan–Meier curves revealed the proportion of MEN2A patients with MTC was significantly different between patients with exon 11 and 10 mutations (P = 0.041, log-rank; Fig. 2a, b-1). This evidence concerns the gene RET and medullary thyroid gland carcinoma.